The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 14, 2023
Filed:
Jun. 16, 2011
Applicant:
Fernand Labrie, Québec, CA;
Inventor:
Fernand Labrie, Québec, CA;
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/35 (2006.01); A61K 31/56 (2006.01); A61K 31/453 (2006.01); A61K 45/06 (2006.01); A61P 5/04 (2006.01); A61P 5/24 (2006.01); A61P 5/30 (2006.01); A61P 15/08 (2006.01); A61P 15/00 (2006.01); A61P 15/02 (2006.01); A61P 25/28 (2006.01); A61P 25/06 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/35 (2013.01); A61K 31/453 (2013.01); A61K 31/56 (2013.01); A61K 45/06 (2013.01); A61P 5/04 (2018.01); A61P 5/24 (2018.01); A61P 5/30 (2018.01); A61P 15/00 (2018.01); A61P 15/02 (2018.01); A61P 15/08 (2018.01); A61P 25/06 (2018.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01);
Abstract
Methods for treating or reducing the likelihood of acquiring estrogen-related (e.g. estrogen-exacerbated) diseases including endometriosis include administering to a patient a selective estrogen receptor modulator (SERM), in combination with inhibiting ovarian secretions, e.g., by administering an LHRH agonist or antagonist. In some embodiments, a precursor of sex steroids, said precursor being selected from the group consisting of dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), androst-5-ene-3β,17β-diol (5 diol), and androstenedione or a compound transformed into one of these, is also administered.